Strategic Investment Management’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-11,336	Closed	-$116K	–	109
2015 Q4	$116K	Buy	+11,336	New	+$116K	0.07%	98
2014 Q3	–	Sell	-20,000	Closed	-$255K	–	105
2014 Q2	$255K	Buy	+20,000	New	+$255K	0.06%	58